ID   Ma-3
AC   CVCL_7068
SY   Ma3
DR   cancercelllines; CVCL_7068
DR   Cosmic; 801595
DR   Cosmic; 844814
DR   Cosmic; 917986
DR   Cosmic; 2668314
DR   IARC_TP53; 11881
DR   Wikidata; Q54903705
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=10536175;
CC   Population: Japanese.
CC   Doubling time: 31.6 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=10536175).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=1650680; DOI=10.1378/chest.100.2.429;
RA   Masuda N., Fukuoka M., Takada M., Kudoh S., Kusunoki Y.;
RT   "Establishment and characterization of 20 human non-small cell lung
RT   cancer cell lines in a serum-free defined medium (ACL-4).";
RL   Chest 100:429-438(1991).
//
RX   PubMed=9393586; DOI=10.1007/s004320050101;
RA   Shimizu E., Zhao M.-R., Shinohara A., Namikawa O., Ogura T., Masuda N.,
RA   Takada M., Fukuoka M., Sone S.;
RT   "Differential expressions of cyclin A and the retinoblastoma gene
RT   product in histological subtypes of lung cancer cell lines.";
RL   J. Cancer Res. Clin. Oncol. 123:533-538(1997).
//
RX   PubMed=10536175; DOI=10.3892/ijo.15.5.927;
RA   Fujita T., Kiyama M., Tomizawa Y., Kohno T., Yokota J.;
RT   "Comprehensive analysis of p53 gene mutation characteristics in lung
RT   carcinoma with special reference to histological subtypes.";
RL   Int. J. Oncol. 15:927-934(1999).
//